Finally, accordingly to previous observations regarding the relationship between AQ1 and patient outcome in carcinomas of different sites, such as ovary, lung, prostate, brain, and breast [14,15,16,19], we have documented a sensible trend for better survival in patients with negative AQP1 immunoexpression. The gene discussed is AQP1; the disease is carcinoma.